HDFC Pharma and Healthcare Fund Reg G

HDFC Pharma and Healthcare Fund-Reg(G)

Equity Sectoral - Pharma Rating : Unrated

₹ 17.58

NAV
Updated: 17 Jul 2025

Fund House

Fund Manager
Nikhil Mathur
Fund Benchmark
BSE Health Care - TRI
Total AUM
₹ 1,786.20 Cr
Expense Ratio
2.06
52 Week High
₹ 17.58
52 Week Low
₹ 13.60

Fund Verdict

Aggressive Buy

Advance Ratios

P/E Ratio17.58
P/B Ratio5.73
Sharpe0.55
Turnover Ratio35.35
Alpha1.66
Beta0.67
Sortino1.10
Standard Deviation14.46

Fund Performance

Shot Term Returns
Duration 1M 3M 6M 1Y
Returns 4.24% 12.81% 6.88% 26.43%
Long Term Returns
Duration 2Y 3Y 5Y 10Y
Returns - - - -

Market Cap Distribution

  • Large Cap
    35.48 %
  • Mid Cap
    25.92 %
  • Small Cap
    36.53 %
Avg Market Cap
₹ 55,531.00
(In Crore)

Peer Information

Equity Sectoral - Pharma Aggressive Buy
1Y Returns 18.58%
3Y Returns 28.93%
AUM ₹5,727.60 Cr
NAV ₹40.63
Buy Now
Equity Sectoral - Pharma Aggressive Buy
1Y Returns 18.11%
3Y Returns 26.34%
AUM ₹1,098.70 Cr
NAV ₹295.39
Buy Now
Equity Sectoral - Pharma Aggressive Buy
1Y Returns 13.40%
3Y Returns 25.71%
AUM ₹3,056.90 Cr
NAV ₹40.22
Buy Now
Equity Sectoral - Pharma Aggressive Buy
1Y Returns 9.45%
3Y Returns 22.53%
AUM ₹840.50 Cr
NAV ₹31.21
Buy Now

Plan Your Long Term Goals

5,000 per month
Duration
Total investment of ₹0
Would have become ₹0

Ready to explore mutual fund investments? Our experts can help you understand the options, risks, and potential returns to build a financial roadmap tailored to your goals. Schedule a consultation today!

Expert Icon
Talk to an Expert

Mutual Funds Specialist

Expert Icon

Plan Smarter. Invest Better. Retire Happier.

Plan Smarter. Invest Better. Retire Happier